Similar articles

• Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism.

  Chiueh CC, Miyake H, Peng MT. Chiueh CC, et al. Adv Neurol. 1993;60:251-8. Adv Neurol. 1993. PMID: 8380519 No abstract available.
• Biochemical mechanisms underlying MPTP-induced and idiopathic parkinsonism. New vistas.

  Singer TP, Ramsay RR, Sonsalla PK, Nicklas WJ, Heikkila RE. Singer TP, et al. Adv Neurol. 1993;60:300-5. Adv Neurol. 1993. PMID: 8380523 Review. No abstract available.
• Monoamine oxidase-B, monoamine oxidase-B inhibitors, and Parkinson's disease. A role for superoxide dismutase?

  Sandler M, Glover V, Clow A, Jarman J. Sandler M, et al. Adv Neurol. 1993;60:238-41. Adv Neurol. 1993. PMID: 8420141 Review. No abstract available.
• Changes of tyrosine hydroxylase in parkinsonian brains and in the brains of MPTP-treated mice.

  Nagatsu T. Nagatsu T. Adv Neurol. 1990;53:207-14. Adv Neurol. 1990. PMID: 1978515 No abstract available.
• Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.

  Graybiel AM, Moratalla R, Quinn B, DeLanney LE, Irwin I, Langston JW. Graybiel AM, et al. Adv Neurol. 1993;60:34-9. Adv Neurol. 1993. PMID: 8420148 No abstract available.